Re-use of erlotinib in a patient using osimertinib after erlotinib, case report.

Pınar Gürsoy Öner

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

The strategy of restarting erlotinib treatment with negative T790M mutation detected in biopsies of patients with osimertinib resistance may be an acceptable treatment option.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
case report
small cell lung cancer
combination therapy
replacement therapy